VEGFA and rheumatoid arthritis: Our findings show that the inhibition of the VEGF pathway by bevacizumab-modulated angiogenesis, inflammation and fibrosis were also described in other tissues in chronic inflammatory conditions, such as during the treatment of rheumatoid arthritis [46].